Leveraging a Modular System Design​ for Mitigating Risk in Bioprocess Manufacturing​

June 04, 2025

Overview

In this presentation, CPC’s Maria Bollensen reviews the benefits of modular systems used in manufacturing biologics and how to ensure that your process remains closed. Both modular and single-use systems present the means to reduce costs, increase productivity, improve quality, reduce risk, and increase flexibility in biopharmaceutical applications.

Attendees will also gain insight into:

  • Closed-system processing and benefits of a modular system design​
  • Testing for process manufacturing to ensure the best outcomes​
  • New standardization coming with United States Pharmacopeia (USP) <665>​ and USP <383>
  • Managing Risk + Process Efficiency: ​The process defines the product​
  • Bioprocessing solutions + Innovation Review: Addressing the bioprocessing goals​

Originally presented at BioProcess International Spring Digital Week 2025